SCHEMBL118630

SCHEMBL118630

[CH2]/C=C\C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20328 1.00
SCHEMBL20329 1.00
SCHEMBL27364218 0.96
SCHEMBL452038 0.79
SCHEMBL7745699 0.72
SCHEMBL83642 0.72
SCHEMBL83643 0.72
SCHEMBL106894 0.71
SCHEMBL106893 0.71
SCHEMBL15771705 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 787 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423739-B Improved enantioselective hydrogenation of 4-substituted 1, 2-dihydroquinolines in the presence of chiral iridium catalysts and additives 拜耳公司 2024-06-25 CN disclosed
CN-113348165-B 1,2, 4-Triazin-3 (2H) -one compounds for the treatment of hyperproliferative diseases 拜耳股份有限公司 2024-06-25 CN disclosed
US-12012467-B2 Small molecule DCN1 inhibitors and therapeutic methods using the same REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-06-18 US disclosed
CN-114514223-B Process for enantioselective hydrogenation of 4-substituted 1, 2-dihydroquinolines comprising using novel iridium catalysts 拜耳公司 2024-05-17 CN disclosed
US-11964938-B2 3-phenyl-4-hexynoic acid derivatives as GPR40 agonists CELON PHARMA S.A. (PL) 2024-04-23 US disclosed
EP-3737470-B9 3-PHENYL-4-HEXYNOIC ACID DERIVATIVES AS GPR40 AGONISTS Celon Pharma Sa (PL) 2024-03-13 EP disclosed
WO-2024041976-A1 PROCESS FOR DISTILLATIVE RECOVERY OF 1,1,1,3,3,3-HEXAFLUORO-2-PROPANOL (HFIP) FROM MIXTURES WITH 4- SUBSTITUTED 1,2,3,4-TETRAHYDROQUINOLINES BAYER AKTIENGESELLSCHAFT (DE) 2024-02-29 WO disclosed
US-11878027-B2 Nicotinamide mononucleotide derivatives and their uses METRO INTERNATIONAL BIOTECH, LLC (US) 2024-01-23 US disclosed
EP-3505555-B1 POLYMER, METHOD FOR PRODUCING POLYMER, AND DRUG CONJUGATE KAWASAKI INST OF INDUSTRIAL PROMOTION (JP) 2024-01-03 EP disclosed
CN-111902399-B Enantioselective hydrogenation of 4-substituted 1, 2-dihydroquinolines in the presence of chiral iridium catalysts 拜耳公司 2023-11-28 CN disclosed
US-5605994-A POLYMERS CONTAINING BIS-IMIDAZOLYL UNITS; METAL SCAVENGERS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1997-02-25 US disclosed
EP-0723543-A1 METAL ION BINDING MONOMER AND POLYMER RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1996-07-31 EP disclosed
US-5455359-A For chelation of heavy metals in waste water treatment RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-10-03 US disclosed
WO-1995009854-A1 METAL ION BINDING MONOMER AND POLYMER RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-04-13 WO disclosed
US-5378729-A Diamide derivatives RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-01-03 US disclosed
EP-0592490-A4 AMINO ACID DERIVATIVE ANTICONVULSANT RES CORP TECHNOLOGIES INC (US) 1994-08-17 EP disclosed
EP-0592490-A1 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-04-20 EP disclosed
WO-1992021648-A1 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1992-12-10 WO disclosed
WO-1990015069-A2 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1990-12-13 WO disclosed
EP-0400440-A1 Amino acid derivative anticonvulsant RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1990-12-05 EP disclosed